B&L lens care solution facility
This article was originally published in The Gray Sheet
Bausch & Lomb's Greenville, S.C., contact lens solution plant clears FDA inspection June 29. The Greenville plant had manufactured the firm's ReNu with MoistureLoc lens care solution, which was withdrawn from the market last May after being linked to reports of fusarium keratitis infections. FDA issued a warning letter to the plant in October, citing failure to promptly notify the agency of adverse events, inadequate process validation, and lack of procedures to prevent product or equipment contamination, among other quality systems concerns (1"The Gray Sheet" Nov. 13, 2006, p. 18). According to B&L, FDA is now satisfied that the firm has completed all of its corrective actions...
You may also be interested in...
Bausch & Lomb has already addressed a majority of the 15 contact lens solution manufacturing and postmarket surveillance violations cited by FDA in a recent 1warning letter, according to the company
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.